CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 10.82%
This Quarter Est. Return
1 Year Est. Return
+10.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$10.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
79
New
Increased
Reduced
Closed

Top Buys

1 +$2.04M
2 +$1.79M
3 +$1.76M
4
CRGY icon
Crescent Energy
CRGY
+$1.56M
5
ALK icon
Alaska Air
ALK
+$1.24M

Top Sells

1 +$2.87M
2 +$2.61M
3 +$1.9M
4
BRKL
Brookline Bancorp
BRKL
+$1.9M
5
NMRK icon
Newmark Group
NMRK
+$1.59M

Sector Composition

1 Healthcare 35.2%
2 Industrials 11.34%
3 Materials 10.84%
4 Consumer Staples 9.52%
5 Technology 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRI icon
51
Herc Holdings
HRI
$4.47B
$875K 0.73%
+7,500
SVC
52
Service Properties Trust
SVC
$294M
$813K 0.68%
300,000
-100,000
OSTX
53
OS Therapies Inc
OSTX
$61.3M
$784K 0.65%
400,000
+25,000
ASRT icon
54
Assertio
ASRT
$72.3M
$638K 0.53%
724,382
NVNO icon
55
enVVeno Medical
NVNO
$8.24M
$544K 0.45%
+600,000
CRIS icon
56
Curis
CRIS
$16.5M
$540K 0.45%
325,000
+105,000
CMPX icon
57
Compass Therapeutics
CMPX
$980M
$525K 0.44%
+150,000
NWL icon
58
Newell Brands
NWL
$1.63B
$524K 0.44%
100,000
PCAR icon
59
PACCAR
PCAR
$55.5B
$492K 0.41%
5,000
LYB icon
60
LyondellBasell Industries
LYB
$15.7B
$490K 0.41%
+10,000
ASH icon
61
Ashland
ASH
$2.67B
$479K 0.4%
+10,000
AVNW icon
62
Aviat Networks
AVNW
$275M
$459K 0.38%
20,000
HELE icon
63
Helen of Troy
HELE
$459M
$378K 0.32%
15,000
+5,000
BCDA icon
64
BioCardia
BCDA
$15.1M
$168K 0.14%
130,000
ELTX icon
65
Elicio Therapeutics
ELTX
$157M
$65.6K 0.05%
6,000
-19,000
APA icon
66
APA Corp
APA
$9.11B
-50,000
BILL icon
67
BILL Holdings
BILL
$5.11B
-10,000
BRKL
68
DELISTED
Brookline Bancorp
BRKL
-180,000
CGTX icon
69
Cognition Therapeutics
CGTX
$144M
-250,000
COHU icon
70
Cohu
COHU
$1.13B
-20,000
EG icon
71
Everest Group
EG
$13.3B
-2,000
FEMY icon
72
Femasys
FEMY
$53.6M
-225,000
FSLR icon
73
First Solar
FSLR
$28.7B
-5,000
B
74
Barrick Mining
B
$71B
-25,000
NKTR icon
75
Nektar Therapeutics
NKTR
$1.24B
-45,000